Clinical and Laboratory Characteristics of 144 Patients with Mediterranean Spotted FeverEster Antón, F. Segura, Isabel Sanfeliú et al.|European Journal of Clinical Microbiology & Infectious Diseases|2003Cited by 212
Randomized trial of doxycycline versus josamycin for Mediterranean spotted feverF. Bella, F. Segura, J Traveria et al.|Antimicrobial Agents and Chemotherapy|1990Cited by 56
Eleven-Year Study of Recurrent Pneumococcal BacteremiaBernat Font, F. Segura, C. Llimiñana et al.|European Journal of Clinical Microbiology & Infectious Diseases|2001Cited by 17
Primary HIV Type-1 Infection Misdiagnosed as Mediterranean Spotted FeverF. Segura, M. Cervantes, E. Ant x F n et al.|European Journal of Clinical Microbiology & Infectious Diseases|2002Cited by 10
Plasma interleukin-6 levels in Mediterranean spotted feverJ. Oristrell, F. Segura, María José Amengual et al.|European Journal of Clinical Microbiology & Infectious Diseases|2004Cited by 8